Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.
Arun, 24, is from Kolkata. He's a bartender. Vidya, 8, studies in an English medium school. Her father is a chaiwala. Purvika, 9, has big, bright eyes. Her father works in a beer bar. All of them are united by one cause alone: To become actors and join the film industry.
Investors accumulated quality stocks at valuable and attractive levels.
Jammu and Kashmir MLA Ramesh Arora wants momos banned, but are they really unhygienic and harmful?
In 2008, Daiichi Sankyo had bought the entire 34.82 per cent stake in Ranbaxy from its promoters, Malvinder Mohan Singh and family, for $4.2 billion. Currently, Singh is executive chairman of Fortis Healthcare.
Gains were led by index heavyweights with Reliance Industries contributing the most.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
Business of retail, food and beverages at duty-free shops in India was estimated to have a potential of $3.5 billion by 2021.
The higher rate cut by RBI is positive for rate-sensitive sectors in the medium to long term.
A glance back at some of the important ups and down Indian Inc faced in 2018.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
Benchmark indices finished higher on hopes of economic reforms
The 30-share Sensex ended down 224 points at 28,442 and the 50-share Nifty ended down 101 points at 8,606.
Indices reversed all its losses during late trades.
US country head, key departmental heads leave; more likely to follow.
Visual appeal or taste, what attracts you to food?
Financials ended mixed despite the status-quo on key rates by the RBI. SBI, ICICI Bank and Axis Bank ended up 0.4-2.5% each.
The rally in index heavyweight ITC has boosted the sentiment across the board.
Stellar rally in ITC shares along with strength in the Asian equities capped the downside.
Lupin will fund the buy through $100 mn cash reserves and a bridge loan.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
Dr Reddy's gets warning from US health regulator
The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.
FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
Market breadth continued to remain strong, with 1899 gainers and 674 losers on the BSEs.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
The S&P BSE Sensex ended 46 points lower at 24,824 and Nifty50 settled at 7,555, down by 8 points after hitting intra-day high of 7,600.45.
The benchmark Nifty rallied 1,000 points or 17% from 7,000 in 78 trading sessions since May 12, till date to surpass the 8,000 mark.
Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
Inspections only in domestic authorities' presence, visiting US drug regulator told
FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.
Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.
The WPI inflation stood at negative 2.4% in May 2015, compared with a negative 2.65% in April 2015.
Rate sensitive sectors rallied the most led by banks while metals surged on rebound in commodity prices
Experts prefer domestic consumption-driven plays and defensives such as information technology and pharmaceuticals
Apart from Maggi noodles, many other products can be tested for health issues.
It's difficult to understand if GDP growth has actually improved.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances